InBody announces home body water measurement solution ‘BWA ON’ at the 2023 World IT Show… “Indicators for predicting chronic diseases, complications, and side effects easily at home!”
InBody (Co-CEO Lee Mi-cheol, Cha Ki-cheol) announced that it will participate in the ‘4 World IT Show (WIS 19)’ to be held at COEX in Seoul from Wednesday, April 21 to Friday, April 2023.
InBody is a global healthcare company that has established itself as a standard in the field of body composition testing and analysis. It has distributed a variety of solutions to hospitals, clinics, and fitness centers under the ‘InBody’ brand, which is familiar to most users. Established 9 overseas local subsidiaries in countries and regions such as the US, Japan, Europe, UK, Germany, China, India, Asia, and Mexico, providing products and services to 109 countries, recording an average annual growth rate of more than 20% It is known that the company is continuing to achieve remarkable results.
InBody has seamlessly transitioned from functional necessities in each specialty field, including medical, nutrition, fitness, and rehabilitation, to products that symbolize professionalism. Furthermore, it is a healthy lifestyle product that allows you to check and manage your InBody results anytime, anywhere, at home, on your wrist, etc. The company explains that it is continuously expanding the market with necessities.
InBody, which boasts such recognition, plans to participate in this exhibition and introduce ‘BWA ON’, a solution that allows chronic disease patients to easily monitor body water at home.
Body water is an indicator highly correlated with disease progression or complications. In particular, in patients with diabetes or heart failure, changes in leg edema can be used to predict diabetic nephropathy, which is a pre-dialysis stage, or to detect and respond to worsening heart failure symptoms early. .
In addition, lymphedema that occurs as a side effect after breast cancer surgery can be diagnosed and prevented early through changes in the affected arm, allowing the patient to respond to complications that threaten the quality of life of breast cancer patients. Accordingly, InBody plans to launch a product line optimized for management and monitoring of diabetes, heart failure, and breast cancer (lymphedema), and plans to expand the range to diseases that require complex management of body water and nutrition, such as chronic renal failure and cancer. It is a policy.
An InBody official said, “BWA ON is a home product for patients with chronic diseases. It enables continuous monitoring in daily life by allowing body water-related indicators, which previously could only be measured in hospitals, to be checked at home and allows quick detection of abnormal signs. “It has meaning,” he explained.
He continued, “BWA ON, which embodies the high specifications of a professional body water meter and the convenience of a scale, allows you to easily measure body composition items necessary to prevent disease progression and complications, such as changes in body water, muscle mass, and body fat percentage, at home and through the web or application. “It was developed to help actively manage disease by enabling communication with medical staff,” he added.
Meanwhile, the ‘World IT Show’, a one-stop platform for digital transformation, is a representative exhibition leading the next-generation high-tech industry. The 2023 World IT Show, with the slogan ‘Changing our life, K-Digital’, will feature △AI, IoT & ICT convergence services △Digital Twin & Metaverse △Smart Living and Healthcare △Robotics The latest technologies and products in the fields of △future mobility such as autonomous driving and UAM, and △blockchain & security will be displayed and introduced. In addition, the ‘WIS 2023 Innovation Award’ and the ‘2023 Korea ImpaCT-ech Grand Prize’ will be awarded to the technologies and products that attract the most attention among participating companies.